EUVIMEDEUVIMED entdecken
Crossref

Discovery of Arylpiperazines with Broad‐Spectrum Antimicrobial Activity and Favorable Pharmacokinetic Profiles

Douglas Davison da Silva Oliveira, Nagela Bernadelli Sousa Silva, Thibault Joseph William Jacques Dit Lapierre, Sara Lemes de Souza, Nícolas Peterson Ferreira Brito, Ana Clara Cassiano Martinho, Renieidy Flávia Clemente Dias, Danilo Nascimento Farago, Simone Michelan-Duarte, Rafael Consolin Chelucci, Mariza Gabriela Faleiro de Moura Lodi Cruz, Daniela de Melo Resende und 5 weitere

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202402100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Douglas Davison da Silva Oliveira und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Síntese de Candidatos a Fármacos (LaSFar), Institute of Chemistry, Federal University of Uberlândia, Uberlândia-MG, 38400-902, Brazil. Hauptthemen laut MEDLINE: Microbial Sensitivity Tests, Piperazines. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microorganisms can induce diseases with significant clinical implications for human health. Multidrug‐resistant microorganisms have been on the rise worldwide over the past few decades, and no new antibiotics have been introduced to the market in a considerable amount of time. Such situation highlights the urgency of discovering new antimicrobial drugs to address this pressing issue. Therefore, the objective of this study was to identify bioactive compounds against 15 species of bacteria and 5 species of fungi of clinical relevance through in vitro screening of 58 synthetic compounds from four chemical classes of our internal library of synthetic compounds. Our findings highlight arylpiperazines 18 , 20 , 26 , 27 , and 29 , and the aminothiazole 50 , as potent broad‐spectrum antimicrobials (MICs=12.5–15.6 μg mL −1 ) against clinically relevant bacteria and fungi. Additionally, these compounds displayed low cytotoxicity against various host cells and a favorable in vitro pharmacokinetic profile for oral administration. Indeed, all six showed adequate lipophilicity, high gastrointestinal permeability, metabolic stability in human and mouse liver microsomes, and satisfactory aqueous solubility. Thus, they emerge as promising starting points for hit‐to‐lead studies towards new antibacterial and antifungal agents, especially against Staphylococcus epidermidis , Staphylococcus aureus , Lactobacillus paracasei and Candida orthopsilosis .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Microbial Sensitivity TestsPiperazinesHumansAnimalsMiceAnti-Bacterial AgentsStructure-Activity RelationshipFungiDrug DiscoveryCandidaBacteriaAntifungal AgentsMicrosomes, LiverMolecular StructureCell SurvivalDose-Response Relationship, DrugAnti-Infective Agents

Stichwörter der Autor:innen

ADMETAminothiazolesAntibioticsAntifungal agentsArylpyperazinesDrug discoveryHit discovery.

Substanzen

PiperazinesAnti-Bacterial AgentsAntifungal AgentsAnti-Infective Agents

Autor:innen und Institutionen

  • Laboratório de Síntese de Candidatos a Fármacos (LaSFar), Institute of Chemistry, Federal University of Uberlândia, Uberlândia-MG, 38400-902, Brazil.
  • Laboratory of Antimicrobial Testing (LEA), Institute of Biomedical Sciences (ICBIM), Federal University of Uberlândia, Uberlândia-MG, 38400-902, Brazil.
  • Laboratório de Química Medicinal e Computacional (LQMC), Instituto de Física de São Carlos (IFSC), Universidade de São Paulo (USP), São Carlos-SP, 13563-120, Brazil.
  • Grupo de Genômica Funcional de Parasitos, Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ Minas), Belo Horizonte-MG, 30190-002, Brazil.

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

da Silva Oliveira, D. D., Sousa Silva, N. B., Jacques Dit Lapierre, T. J. W., Lemes de Souza, S., Ferreira Brito, N. P., Cassiano Martinho, A. C., Clemente Dias, R. F., Nascimento Farago, D., Michelan-Duarte, S., Consolin Chelucci, R., de Moura Lodi Cruz, M. G. F., de Melo Resende, D., Andricopulo, A. D., Fonseca Murta, S. M., Ferreira, L. L. G., Martins, C. H. G., & de Oliveira Rezende Júnior, C. (2025). Discovery of Arylpiperazines with Broad‐Spectrum Antimicrobial Activity and Favorable Pharmacokinetic Profiles. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402100

Vancouver

da Silva Oliveira DD, Sousa Silva NB, Jacques Dit Lapierre TJW, Lemes de Souza S, Ferreira Brito NP, Cassiano Martinho AC, et al. Discovery of Arylpiperazines with Broad‐Spectrum Antimicrobial Activity and Favorable Pharmacokinetic Profiles. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402100

BibTeX
@article{daSilvaOliveira2025,
  author = {da Silva Oliveira, Douglas Davison and Sousa Silva, Nagela Bernadelli and Jacques Dit Lapierre, Thibault Joseph William and Lemes de Souza, Sara and Ferreira Brito, Nícolas Peterson and Cassiano Martinho, Ana Clara and Clemente Dias, Renieidy Flávia and Nascimento Farago, Danilo and Michelan-Duarte, Simone and Consolin Chelucci, Rafael and de Moura Lodi Cruz, Mariza Gabriela Faleiro and de Melo Resende, Daniela and Andricopulo, Adriano D and Fonseca Murta, Silvane Maria and Ferreira, Leonardo L G and Martins, Carlos Henrique Gomes and de Oliveira Rezende Júnior, Celso},
  title = {Discovery of Arylpiperazines with Broad‐Spectrum Antimicrobial Activity and Favorable Pharmacokinetic Profiles},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202402100}
}
Kostenlos starten →